Universal-Beteiligungs- und Servicegesellschaft’s TG Therapeutics TGTX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	24,448 -1,522	-6%	-$62.3K	﹤0.01%	1454
2026 Q1	$863K	Sell	25,970 -24,912	-49%	-$742K	﹤0.01%	1560
2025 Q4	$1.52M	Sell	50,882 -12,416	-20%	-$406K	﹤0.01%	1356
2025 Q3	$2.29M	Sell	63,298 -129,025	-67%	-$4.25M	﹤0.01%	1234
2025 Q2	$6.92M	Sell	192,323 -6,727	-3%	-$250K	0.01%	695
2025 Q1	$7.85M	Buy	+199,050	New	+$6.7M	0.02%	639

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's TGTX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its TG Therapeutics (TGTX) stake by 5.9% in Q2 2026, selling an estimated $62.3K and leaving 24,448 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1454.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in TGTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.85M in Q1 2025. 303 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 24,448 shares of TG Therapeutics worth $1.34M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 1,522 TG Therapeutics shares in Q2 2026, an estimated $62.3K.
TG Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1454 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in TG Therapeutics in Q1 2025 and has held it in 6 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's TG Therapeutics position peaked at $7.85M in Q1 2025.
303 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.